Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNTO 6785 in active rheumatoid arthritis despite methotrexate
NCT01909427Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2013
- Primary completion
- Dec 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of CNTO 6785 in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Jun 2013; status: completed.
02
Drugs
CNTO 6785
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01909427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01909427.